Loading…
InspireMD, Inc. is projected to decline to $0.6585 by 2027, a -8% move from its current price of $0.7121. NSPR is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.6883 | $0.7121 | $0.7367 | 0.00% |
| Jul 13 | $0.6787 | $0.7121 | $0.7471 | 0.00% |
| Jul 14 | $0.6714 | $0.7121 | $0.7552 | 0.00% |
| Jul 15 | $0.6654 | $0.7121 | $0.7621 | 0.00% |
| Jul 16 | $0.6601 | $0.7121 | $0.7682 | 0.00% |
| Jul 17 | $0.6553 | $0.7121 | $0.7738 | 0.00% |
| Jul 18 | $0.6509 | $0.7121 | $0.7789 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6509 | $0.7121 | $0.7789 | -0.01% |
| Week 2 | $0.6271 | $0.712 | $0.8084 | -0.01% |
| Week 3 | $0.6095 | $0.712 | $0.8317 | -0.02% |
| Week 4 | $0.595 | $0.7119 | $0.8519 | -0.02% |
| Week 5 | $0.5824 | $0.7119 | $0.8701 | -0.03% |
| Week 6 | $0.5714 | $0.7119 | $0.8869 | -0.03% |
| Week 7 | $0.5614 | $0.7118 | $0.9026 | -0.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InspireMD, Inc. is a healthcare company focused on the development and commercialization of medical devices for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. Its portfolio includes MicroNet, a biocompatible polymer mesh material for medical implants, and CGuard carotid embolic prevention system (EPS) for carotid artery applications, along with the CGuard Prime Carotid Stent System and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions.
The company was founded in 2005 and is headquartered in Miami, Florida.
InspireMD, Inc. (NSPR) is a healthcare company with a current price of $0.72 and a market capitalization of $33.72M. It is ranked 4699 by market capitalization.
A major floor 37.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 41.8% above — a clean break opens room to run.
A major ceiling 154.2% above — clearing it would confirm fresh momentum.
Key NSPR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NSPR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.71 | Buy | $0.7093 | Buy |
| MA 10 | $0.703 | Buy | $0.7092 | Buy |
| MA 20 | $0.7095 | Buy | $0.7399 | Sell |
| MA 50 | $0.9016 | Sell | $0.9057 | Sell |
| MA 100 | $1.24 | Sell | $1.16 | Sell |
| MA 200 | $1.61 | Sell | $1.50 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.07 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 42.17 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 2.86 | Buy |
| Bollinger %B (20,2) | 0.62 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -1.27 | Sell |
| Awesome (5,34) | -0.08 | Sell |
| Ultimate (7,14,28) | 53.52 | Neutral |
| Momentum (10) | 0.06 | Buy |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 0.71 | Sell |
| ADX (14) | 31.86 | Sell |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The 50-day simple moving average (SMA) is $1.02 and the 200-day SMA is $1.70. The stock’s nearest support is at $0.66 and resistance at $1.17. Over the last 30 days, the price has traded in a range from $0.5698 to $0.9098.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.66 | $0.7121 | $0.8874 | 0% | Neutral | |
| $0.5124 | $0.6585 | $0.9022 | -8% | Neutral | |
| $0.4998 | $0.6655 | $0.9531 | -7% | Neutral | |
| $0.5789 | $0.7941 | $1.18 | +12% | Neutral | |
| $0.5976 | $0.8417 | $1.28 | +18% | Neutral | |
| $0.6087 | $0.8784 | $1.37 | +23% | Bullish | |
| $0.5835 | $0.8612 | $1.38 | +21% | Bullish | |
| $0.5281 | $0.7963 | $1.30 | +12% | Neutral | |
| $0.5229 | $0.8048 | $1.34 | +13% | Neutral | |
| $0.5695 | $0.8939 | $1.51 | +26% | Bullish | |
| $0.632 | $1.09 | $1.97 | +52% | Bullish | |
| $1.14 | $2.31 | $4.65 | +224% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.66 | $0.7121 | $0.8339 | +0.00% |
| August 2026 | $0.5838 | $0.6937 | $0.8498 | -2.58% |
| September 2026 | $0.5936 | $0.7116 | $0.8836 | +2.58% |
| October 2026 | $0.5748 | $0.6942 | $0.8719 | -2.45% |
| November 2026 | $0.5531 | $0.6723 | $0.8526 | -3.14% |
| December 2026 | $0.5673 | $0.6937 | $0.8874 | +3.18% |
Click any year to see its month-by-month NSPR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NSPR is projected to trade between $0.66 and $0.8874, averaging $0.7121 — a potential gain of 0% from today's $0.7121. Price action looks broadly range-bound.
InspireMD, Inc.'s 2027 outlook centres on $0.6585, within a $0.5124 to $0.9022 range. That is -8% versus the projected 2026 average. That marks a -8% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NSPR could reach as high as $0.9531, with a base case around $0.6655 and support toward $0.4998 — roughly -7% from $0.7121. Price action looks broadly range-bound.
Expect NSPR to range from $0.5789 to $1.18 through 2029. The $0.7941 average target implies a +12% move from current prices. That is up +19% on the projected 2028 average. A consolidation phase looks the most probable path here.
The NSPR price prediction for 2030 points to an average of $0.8417 (low $0.5976, high $1.28) — a potential gain of +18% on today's $0.7121. Price action looks broadly range-bound.
In 2031, NSPR is projected to trade between $0.6087 and $1.37, averaging $0.8784 — a potential gain of +23% from today's $0.7121. That is up +4% on the projected 2030 average. Buyers look set to stay in control over this stretch.
InspireMD, Inc.'s 2032 outlook centres on $0.8612, within a $0.5835 to $1.38 range. That is -2% versus the projected 2031 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2033, NSPR could reach as high as $1.30, with a base case around $0.7963 and support toward $0.5281 — roughly +12% from $0.7121. A consolidation phase looks the most probable path here.
Expect NSPR to range from $0.5229 to $1.34 through 2034. The $0.8048 average target implies a +13% move from current prices. That is up +1% on the projected 2033 average. Price action looks broadly range-bound.
The NSPR price prediction for 2035 points to an average of $0.8939 (low $0.5695, high $1.51) — a potential gain of +26% on today's $0.7121. Buyers look set to stay in control over this stretch.
In 2040, NSPR is projected to trade between $0.632 and $1.97, averaging $1.09 — a potential gain of +52% from today's $0.7121. That is up +21% on the projected 2035 average. Momentum favours further upside here.
InspireMD, Inc.'s 2050 outlook centres on $2.31, within a $1.14 to $4.65 range. That is up +113% on the projected 2040 average. That marks a +224% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NSPR today (≈ 1,404.297149 NSPR) could be worth
$3,241.94
+$2,241.94 (+224%) by 2050 · US Dollar
Based on the average projected NSPR price of $2.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NSPRwould be worth at today's price.
$1,000 invested in NSPR on Jul 10, 2025 (≈ 411.522622 NSPR) would be worth
$293.05
-$706.95 (-70.7%) today · 0.29× · US Dollar
Based on a NSPR entry price of $2.43 vs. today's $0.7121.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.7 | $1,017.29 | +1.7% |
| 1 month ago | $0.78 | $912.95 | -8.7% |
| 3 months ago | $1.29 | $552.02 | -44.8% |
| 6 months ago | $1.62 | $439.57 | -56.0% |
| 1 year ago | $2.43 | $293.05 | -70.7% |
| All time (5.0y) ago | $4.76 | $149.6 | -85.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NSPR forecast.
Our base-case forecast reaches $1.40 around 2050.
Implied market cap at $1.40: $65.57M
The multi-year forecast shows a path of gradual upside. For 2026, the min is $0.66, the avg is $0.72, the max is $0.9207 with ROI 0% and sentiment NEUTRAL. In 2030, the avg is $0.8431 with ROI 17.1% and sentiment NEUTRAL.
The forecast for 2031 and 2032 is bullish, with 2031 avg $0.8914 and 2032 avg $0.8826 (ROI 23.8% and 22.6%, respectively). By 2040, the avg is $1.10 with a max of $2.03 and ROI 52.3%, sentiment BULLISH, and by 2050 the avg is $2.38 with a max of $4.89 and ROI 230.6%, sentiment BULLISH. These figures illustrate a potential long-term upside but are estimates, not guarantees.
Tap a question to reveal the answer.
Avg $0.8431; min $0.5917; max $1.30; ROI 17.1%; sentiment NEUTRAL.
Near-term outlook is NEUTRAL with 2026 avg $0.72 and ROI 0%. The forecast shows negative ROIs in 2027 (-9.1%) and 2028 (-8.1%), then positive returns in 2029 (ROI 13.2%), 2030 (ROI 17.1%), 2031 (ROI 23.8%), 2040 (ROI 52.3%), and 2050 (ROI 230.6%). These are estimates and not guarantees.
According to the forecast, the 2040 max is $2.03 and the 2050 max is $4.89; the 2030 max is $1.30, indicating higher trajectories later in the horizon.
Current price is $0.72 and market capitalization is $33.72M.
RSI14 is 30. The 50-day SMA is $1.02 and the 200-day SMA is $1.70. The 30-day range is $0.5698–$0.9098, with support at $0.66 and resistance at $1.17. Annualized volatility is 70%.
InspireMD, Inc. Community Discussion
0Share your InspireMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.